Suppr超能文献

眼周肉毒毒素对泪膜稳态和眼表改变的综述。

A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change.

机构信息

Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 33302, Taiwan.

Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

出版信息

Toxins (Basel). 2019 Jan 24;11(2):66. doi: 10.3390/toxins11020066.

Abstract

Clinical usage of botulinum neurotoxin (BoNT) in ophthalmology has dramatically increased since the 1980s and has become one of the most widely used agents for treating facial movement disorders, autonomic dysfunction and aesthetic wrinkles. Despite its high efficacy, there are some complications with periocular BoNT injections due to its chemodenervation effect. Among these, there is still controversy over the BoNT effect on tear film homeostasis and the ocular surface. A periocular BoNT injection could dry the eye by reducing tear production of the lacrimal gland and increase tear evaporation due to potential eyelid malposition and abnormal blinks. On the contrary, the injection of BoNT in the medial eyelids could treat dry eye disease by impairing lacrimal drainage. Regarding the ocular surface change, corneal astigmatism and high-order aberrations may decrease due to less eyelid tension. In conclusion, the entire awareness of the effect of BoNT and the patients' ocular condition is crucial for successful and safe results.

摘要

自 20 世纪 80 年代以来,肉毒毒素(BoNT)在眼科的临床应用显著增加,已成为治疗面部运动障碍、自主神经功能障碍和美容皱纹最广泛使用的药物之一。尽管其疗效很高,但由于其化学去神经作用,眶周 BoNT 注射会引起一些并发症。其中,BoNT 对泪膜稳态和眼表的影响仍存在争议。眶周 BoNT 注射可能会因潜在的眼睑位置不正和异常眨眼而减少泪液分泌,增加泪液蒸发,从而使眼睛变干。相反,内侧眼睑注射 BoNT 可能会通过损害泪液引流来治疗干眼症。关于眼表的变化,由于眼睑张力降低,角膜散光和高阶像差可能会减小。总之,对 BoNT 作用的全面认识和患者的眼部状况对于获得成功和安全的结果至关重要。

相似文献

3
[A new approach for better comprehension of diseases of the ocular surface].
J Fr Ophtalmol. 2007 Mar;30(3):239-46. doi: 10.1016/s0181-5512(07)89584-2.
4
Effect of eyelid botulinum toxin injection on lacrimal drainage.
Am J Ophthalmol. 2000 Apr;129(4):481-6. doi: 10.1016/s0002-9394(99)00408-0.
5
Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
J Fr Ophtalmol. 2018 Apr;41(4):343-349. doi: 10.1016/j.jfo.2017.11.010. Epub 2018 Apr 19.
7
Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):331-338. doi: 10.1007/s00417-018-4194-3. Epub 2018 Dec 14.
9
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Arch Ophthalmol. 2009 Apr;127(4):525-32. doi: 10.1001/archophthalmol.2009.52.
10
Botulinum Toxin A Injection for the Treatment of Intractable Dry Eye Disease.
Medicina (Kaunas). 2021 Mar 8;57(3):247. doi: 10.3390/medicina57030247.

引用本文的文献

1
Oculoplastic Interventions in the Management of Ocular Surface Diseases: A Comprehensive Review.
Life (Basel). 2025 Jul 16;15(7):1110. doi: 10.3390/life15071110.
2
Is Botulinum toxin A effective in treating dry eye disease? A systematic review and meta-analysis.
Eye (Lond). 2025 Jun;39(8):1457-1464. doi: 10.1038/s41433-025-03790-6. Epub 2025 Apr 9.
3
Effectiveness and safety of botulinum toxin type A combined with blepharoplasty in treating sagging skin around the eyes.
Heliyon. 2024 Sep 5;10(18):e37407. doi: 10.1016/j.heliyon.2024.e37407. eCollection 2024 Sep 30.
4
Botulinum toxin treatment for hemifacial spasm: harmonising neurological and aesthetic outcomes.
J Neural Transm (Vienna). 2025 Jan;132(1):23-38. doi: 10.1007/s00702-024-02821-y. Epub 2024 Aug 23.
5
TFOS Lifestyle: Impact of cosmetics on the ocular surface.
Ocul Surf. 2023 Jul;29:77-130. doi: 10.1016/j.jtos.2023.04.005. Epub 2023 Apr 13.
6
Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease.
Clin Exp Optom. 2022 Mar;105(2):177-185. doi: 10.1080/08164622.2021.1962210. Epub 2021 Aug 8.
7
Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.
Clin Ophthalmol. 2021 Apr 28;15:1775-1782. doi: 10.2147/OPTH.S305817. eCollection 2021.

本文引用的文献

1
Impact of blinking on ocular surface and tear film parameters.
Ocul Surf. 2018 Oct;16(4):424-429. doi: 10.1016/j.jtos.2018.06.001. Epub 2018 Jun 5.
3
Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
J Fr Ophtalmol. 2018 Apr;41(4):343-349. doi: 10.1016/j.jfo.2017.11.010. Epub 2018 Apr 19.
4
Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
J Fr Ophtalmol. 2017 Oct;40(8):661-665. doi: 10.1016/j.jfo.2017.03.006. Epub 2017 Aug 25.
5
TFOS DEWS II Definition and Classification Report.
Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
8
Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye.
Acta Ophthalmol. 2017 Mar;95(2):e132-e137. doi: 10.1111/aos.13140. Epub 2016 Jun 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验